Cargando…
Understanding Glioblastoma Signaling, Heterogeneity, Invasiveness, and Drug Delivery Barriers
The most prevalent and aggressive type of brain cancer, namely, glioblastoma (GBM), is characterized by intra- and inter-tumor heterogeneity and strong spreading capacity, which makes treatment ineffective. A true therapeutic answer is still in its infancy despite various studies that have made sign...
Autores principales: | Rabah, Nadin, Ait Mohand, Fatima-Ezzahra, Kravchenko-Balasha, Nataly |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532387/ https://www.ncbi.nlm.nih.gov/pubmed/37762559 http://dx.doi.org/10.3390/ijms241814256 |
Ejemplares similares
-
Paclitaxel Delivery to the Brain for Glioblastoma Treatment
por: AbdEl-haq, Muhammad, et al.
Publicado: (2023) -
Decoding cancer heterogeneity: studying patient-specific signaling signatures towards personalized cancer therapy
por: Flashner-Abramson, Efrat, et al.
Publicado: (2019) -
Heterogeneity of Gene Expression in Murine Squamous Cell Carcinoma Development—The Same Tumor by Different Means
por: Cohen, Noam, et al.
Publicado: (2013) -
Drug-Induced Resistance and Phenotypic Switch in Triple-Negative Breast Cancer Can Be Controlled via Resolution and Targeting of Individualized Signaling Signatures
por: Vasudevan, Swetha, et al.
Publicado: (2021) -
Anomalous Features of EMT during Keratinocyte Transformation
por: Geiger, Tamar, et al.
Publicado: (2008)